This is largely due to their high sensitivity (0.90) but low specificity (0.20), which leads to a substantial number of unnecessary biopsies, as reported in reviews included in clinical practice guidelines
Looking for Physician-Supervised GLP-1 Therapy
Ciplas Yurpeak itself an innovator launch, Lillys tirzepatide sold under a Cipla brand did 14 crore in its first month
Your provider will determine whether side effects warrant dose reduction, temporary pause, or discontinuation
Diana Harshbarger, R-Tenn., who last year wrote to Kennedy, asking that compounders be allowed to make certain peptides
High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis